RadNet/$RDNT
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About RadNet
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
- Ticker
- $RDNT
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 9,060
- Headquarters
- Los Angeles, United States
- Website
- www.radnet.com
RadNet Metrics
BasicAdvanced
$6.1B
-
-$0.27
1.40
-
Price and volume
Market cap
$6.1B
Beta
1.4
52-week high
$85.84
52-week low
$50.82
Average daily volume
613K
Financial strength
Current ratio
1.484
Quick ratio
1.397
Long term debt to equity
1.494
Total debt to equity
1.567
Interest coverage (TTM)
1.45%
Profitability
EBITDA (TTM)
276.146
Gross margin (TTM)
17.28%
Net profit margin (TTM)
-0.93%
Operating margin (TTM)
4.76%
Effective tax rate (TTM)
44.90%
Revenue per employee (TTM)
$250,000
Management effectiveness
Return on assets (TTM)
1.74%
Return on equity (TTM)
1.50%
Valuation
Price to revenue (TTM)
2.643
Price to book
5.6
Price to tangible book (TTM)
-22.58
Price to free cash flow (TTM)
82.855
Free cash flow yield (TTM)
1.21%
Free cash flow per share (TTM)
0.942
Growth
Revenue change (TTM)
18.92%
Earnings per share change (TTM)
36.13%
3-year revenue growth (CAGR)
14.08%
10-year revenue growth (CAGR)
10.20%
3-year earnings per share growth (CAGR)
7.32%
10-year earnings per share growth (CAGR)
1.35%
What the Analysts think about RadNet
Analyst ratings (Buy, Hold, Sell) for RadNet stock.
Analyst projections of the future price of RadNet stock.
Bulls say / Bears say
Imaging demand is strong: second-quarter revenue rose 25%, while same-centre advanced-imaging volumes grew 9.6%. RadNet also raised its 2026 imaging revenue, adjusted EBITDA and free-cash-flow guidance. (RadNet)
Digital Health could become a second growth engine: annual recurring revenue nearly doubled to $105.5 million, with 63% generated by external customers. FDA clearance for its breast-ultrasound AI adds a new product opportunity. (RadNet)
The proposed ONRAD acquisition would extend RadNet into hospital-based radiology staffing, complementing its imaging centres and software. RadNet says ONRAD has grown revenue by 10%–20% annually and has adjusted EBITDA margins above 30%. (RadNet)
Profit growth is lagging sales: second-quarter net income attributable to common shareholders fell to $7.5 million from $14.5 million, while adjusted EPS declined to $0.29 from $0.34 despite 25% revenue growth. (RadNet)
Digital Health growth is not yet translating into stronger segment earnings: revenue rose 56.5%, but adjusted EBITDA fell 27.2% to $2.5 million. RadNet’s 2026 guidance also implies negative free cash flow after planned research and development spending. (RadNet)
ONRAD adds sizeable funding and integration risks: the deal calls for $350 million in cash and 5 million RadNet shares, with a further earnout of up to $210 million. It is not expected to close until 2027 and remains subject to regulatory review and other conditions. (RadNet)
Data summarised monthly by Lightyear AI. Last updated on 27 Oct 2026.
RadNet Financial Performance
Revenues and expenses
RadNet Earnings Performance
Company profitability
Upcoming events
No upcoming events
RadNet News
AllArticlesVideos
Funds containing RadNet
AllUSDEURGBP
Fund name | Fund size | $RDNT weighting |
|---|---|---|
iShares Ageing Population$AGED | $953M | 0.51% |
iShares Ageing Population£AGES | $953M | 0.51% |
iShares Ageing Population€AGED | $903M | 0.51% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.32% |
iShares S&P Small Cap 600£ISP6 | $3.2B | 0.32% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.